Bo Shan Ph.D.
CEO
■ Ph.D., Aston University, UK
■ CSO, Antengene Ltd HK listed company
■ VP, Ascletis Ltd HK listed company
■ ED, Shanghai ChemPartner, China
■ GE Healthcare UK
■ Ph.D., Aston University, UK
■ CSO, Antengene Ltd HK listed company
■ VP, Ascletis Ltd HK listed company
■ ED, Shanghai ChemPartner, China
■ GE Healthcare UK
■ Distinguished Young Scholar of National Science Foundation of China
■ Peking University Boya Professor
■ Leading Scientist, Changping Laboratory
■ Joint PI, Peking-Tsinghua Centre for Life Sciences
■ Adjunct Professor of Beijing Cancer Hospital
■ Ph.D., University of British Columbia, TRIUMF
■ Postdoctoral Research Fellow, National Institutes of Health
■ Ph.D., Jiaotong University School of Medicine
■ VP, Clinical Research, IMAB Ltd
■ ED, Clinical Development, Antengene Ltd
■ Director, Clinical Development, Beigene Ltd
■ Associate Medical Director, PAREXEL
■ 15+ years physician, 10+ years in clinical devel.
■ Ph.D., Nanyang Technological University, Singapore
■ SD, Medicinal Chemistry, Shanghai Haiyan
■ Director, WuXi AppTec DDSU
■ Senior Scientist, Shanghai ChemPartner
■ Obtained 7 PCCs and 7 CTAs, 2 in Phase II and 3 in Phase I
■ MSc, Nanjing University
■ Researcher, SPH Central Research Center
■ General Manager , YiTai Pharmaceutical
■ Deputy GM, MITRO Clinical
■ 15+ years in clinical operations